Title : Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.

Pub. Date : 2017 Jul

PMID : 28662936






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The angiotensin receptor neprilysin inhibitor (ARNI) sacubitril/valsartan, which has been shown to benefit patients with heart failure (HF) and reduced ejection fraction, demonstrated favorable physiologic effects in a phase II HFpEF trial. Valsartan membrane metalloendopeptidase Homo sapiens